BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34078309)

  • 1. Prophylactic gastrostomy in locally advanced head and neck cancer: results of a national survey among radiation oncologists.
    Dragan T; Duprez F; Van Gossum A; Gulyban A; Beauvois S; Digonnet A; Lalami Y; Van Gestel D
    BMC Cancer; 2021 Jun; 21(1):656. PubMed ID: 34078309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction model for tube feeding dependency during chemoradiotherapy for at least four weeks in head and neck cancer patients: A tool for prophylactic gastrostomy decision making.
    Willemsen ACH; Kok A; van Kuijk SMJ; Baijens LWJ; de Bree R; Devriese LA; Hoebers FJP; Lalisang RI; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2020 Aug; 39(8):2600-2608. PubMed ID: 31839429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Nutritional and Clinical Outcomes in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy Utilizing Prophylactic versus Reactive Nutrition Support Approaches.
    Brown TE; Banks MD; Hughes BGM; Lin CY; Kenny LM; Bauer JD
    J Acad Nutr Diet; 2018 Apr; 118(4):627-636. PubMed ID: 27986517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrostomy vs nasogastric tube feeding in patients with head and neck cancer during radiotherapy alone or combined chemoradiotherapy.
    Soria A; Santacruz E; Vega-Piñeiro B; Gión M; Molina J; Villamayor M; Mateo R; Riveiro J; Nattero L; Botella-Carretero JI
    Nutr Hosp; 2017 Jun; 34(3):512-516. PubMed ID: 28627183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic versus reactive gastrostomy tube placement in advanced head and neck cancer treated with definitive chemoradiotherapy: A systematic review.
    McClelland S; Andrews JZ; Chaudhry H; Teckie S; Goenka A
    Oral Oncol; 2018 Dec; 87():77-81. PubMed ID: 30527247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early percutaneous endoscopic gastrostomy and nutritional supplementation for patients with head and neck cancer: an Italian survey of head and neck radiation oncologists.
    Trignani M; Di Pilla A; Taraborrelli M; Perrotti F; Caponigro G; Santarelli G; Campitelli G; Croce A; De Nicola M; Genovesi D
    Support Care Cancer; 2015 Dec; 23(12):3539-43. PubMed ID: 25855041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteral tube feeding of head and neck cancer patients undergoing definitive chemoradiotherapy in the Nordic Countries: Survey of the Scandinavian Society for Head and Neck Oncology.
    Ilmarinen T; Hammarstedt-Nordenvall L; Bäck L; Mäkitie A
    Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3489-3496. PubMed ID: 33389006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age most significant predictor of requiring enteral feeding in head-and-neck cancer patients.
    Sachdev S; Refaat T; Bacchus ID; Sathiaseelan V; Mittal BB
    Radiat Oncol; 2015 Apr; 10():93. PubMed ID: 25896830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prophylactic percutaneous endoscopic gastrostomy with reactive enteral nutrition in patients with head and neck cancer undergoing radiotherapy or chemoradiotherapy: A systematic review.
    Mellors K; Ye X; Van Den Brande J; Wai Ray Mak T; Brown T; Findlay M; Bauer J
    Clin Nutr ESPEN; 2021 Dec; 46():87-98. PubMed ID: 34857252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteral feeding in head and neck cancer patients at a UK cancer centre.
    Sheth CH; Sharp S; Walters ER
    J Hum Nutr Diet; 2013 Oct; 26(5):421-8. PubMed ID: 23379517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study comparing prophylactic gastrostomy to nutritional counselling with a therapeutic feeding tube if required in head and neck cancer patients undergoing chemoradiotherapy in Thai real-world practice.
    Pramyothin P; Manyanont S; Trakarnsanga A; Petsuksiri J; Ithimakin S
    J Hum Nutr Diet; 2016 Dec; 29(6):768-776. PubMed ID: 27028666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
    Karsten RT; Stuiver MM; van der Molen L; Navran A; de Boer JP; Hilgers FJM; Klop WMC; Smeele LE
    Oral Oncol; 2019 Jan; 88():172-179. PubMed ID: 30616790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of prophylactic percutaneous endoscopic gastrostomy tube in head and neck cancer patients undergoing concurrent chemoradiation: A prospective observational cohort.
    Dechaphunkul T; Soonthornrak P; Geater SL; Dechaphunkul A
    Am J Otolaryngol; 2022; 43(4):103512. PubMed ID: 35636089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin.
    Yang W; McNutt TR; Dudley SA; Kumar R; Starmer HM; Gourin CG; Moore JA; Evans K; Allen M; Agrawal N; Richmon JD; Chung CH; Quon H
    Dysphagia; 2016 Apr; 31(2):206-13. PubMed ID: 26753929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic gastrostomy placement and early tube feeding may limit loss of weight during chemoradiotherapy for advanced head and neck cancer, a preliminary study.
    Wiggenraad RG; Flierman L; Goossens A; Brand R; Verschuur HP; Croll GA; Moser LE; Vriesendorp R
    Clin Otolaryngol; 2007 Oct; 32(5):384-90. PubMed ID: 17883560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy.
    Nugent B; Lewis S; O'Sullivan JM
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD007904. PubMed ID: 23440820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors for tube feeding dependence after curative (chemo-) radiation in head and neck cancer: A systematic review of literature.
    Wopken K; Bijl HP; Langendijk JA
    Radiother Oncol; 2018 Jan; 126(1):56-67. PubMed ID: 28943045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and external validation of a prediction model for tube feeding dependency for at least four weeks during chemoradiotherapy for head and neck cancer.
    Willemsen ACH; Kok A; Baijens LWJ; de Boer JP; de Bree R; Devriese LA; Driessen CML; van Herpen CML; Hoebers FJP; Kaanders JHAM; Karsten RT; van Kuijk SMJ; Lalisang RI; Navran A; Pereboom SR; Schols AMWJ; Terhaard CHJ; Hoeben A
    Clin Nutr; 2022 Jan; 41(1):177-185. PubMed ID: 34883306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tube feeding in patients with head and neck cancer undergoing chemoradiotherapy: A systematic review.
    Bossola M; Antocicco M; Pepe G
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1258-1269. PubMed ID: 35244947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.